Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;24(41):1900598.
doi: 10.2807/1560-7917.ES.2019.24.41.1900598.

Estimating the 'PrEP Gap': how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019

Rosalie Hayes  1 , Axel J Schmidt  2   3 , Anastasia Pharris  4 , Yusef Azad  1 , Alison E Brown  5   6 , Peter Weatherburn  2 , Ford Hickson  2 , Valerie Delpech  5   7 , Teymur Noori  4 ; ECDC Dublin Declaration Monitoring Network  8
Affiliations

Estimating the 'PrEP Gap': how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019

Rosalie Hayes et al. Euro Surveill. 2019 Oct.

Erratum in

  • Erratum for Euro Surveill. 2019;24(41).
    Eurosurveillance editorial team. Eurosurveillance editorial team. Euro Surveill. 2019 Nov;24(46):1911141. doi: 10.2807/1560-7917.ES.2019.24.46.1911141. Euro Surveill. 2019. PMID: 31771706 Free PMC article. No abstract available.

Abstract

In 2019, only 14 European and Central Asian countries provided reimbursed HIV pre-exposure prophylaxis (PrEP). Using EMIS-2017 data, we present the difference between self-reported use and expressed need for PrEP in individual countries and the European Union (EU). We estimate that 500,000 men who have sex with men in the EU cannot access PrEP, although they would be very likely to use it. PrEP's potential to eliminate HIV is currently unrealised by national healthcare systems.

Keywords: Europe and Central Asia; European Union; Human Immunodeficiency Virus (HIV); Men who have sex with Men (MSM); Pre-exposure prophylaxis (PrEP).

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure 1
Figure 1
Status of PrEP implementation, Dublin Declaration monitoring in Europe and Central Asia, September 2019 (n = 53)
Figure 2
Figure 2
Country reported barriers to implementing PrEP, Dublin Declaration monitoring in Europe and Central Asia, 2018 (n = 32 countries)
Figure 3
Figure 3
People using PrEP in the last 12 months, by rate per 100,000 adult populationa, Dublin Declaration monitoring in Europe and Central Asia, 2019 (n = 20)
Figure 4
Figure 4
The PrEP Gap – the proportion of non-HIV-diagnosed MSM ‘very likely’ to use PrEP if accessible, compared with the proportion currently using PrEP from any source, EMIS-2017 qualifying countries, January 2018 (n=44 countries; n = 112,748 respondents)
See this image and copyright information in PMC

References

    1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-99. 10.1056/NEJMoa1011205 - DOI - PMC - PubMed
    1. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53-60. 10.1016/S0140-6736(15)00056-2 - DOI - PMC - PubMed
    1. Molina J-M, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand pre-exposure prophylaxis in men at high risk for HIV-1 Infection. N Engl J Med. 2015;373(23):2237-46. 10.1056/NEJMoa1506273 - DOI - PubMed
    1. Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11):e629-37. 10.1016/S2352-3018(18)30215-7 - DOI - PubMed
    1. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Strategy 2016-2021. Geneva, UNAIDS; Switzerland; 2015.

MeSH terms

Substances